HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

trilostane

inhibits conversion of pregnenolone to progesterone; adrenal blocking agent used in treatment of Cushing's syndrome
Also Known As:
4alpha,5-epoxy-17beta-hydroxy-3-oxoandrostane-2-carbonitrile; Modrenal; WIN 24,540
Networked: 171 relevant articles (26 outcomes, 15 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Neiger, R: 9 articles (01/2014 - 06/2002)
2. Reusch, C E: 7 articles (09/2016 - 07/2006)
3. Ramsey, I K: 7 articles (03/2011 - 09/2005)
4. Boretti, F S: 6 articles (09/2016 - 07/2006)
5. Sieber-Ruckstuhl, N S: 6 articles (09/2016 - 07/2006)
6. Tebb, A J: 5 articles (03/2011 - 11/2005)
7. Ramsey, I: 4 articles (12/2016 - 06/2002)
8. Arenas Bermejo, Carolina: 3 articles (01/2022 - 07/2020)
9. García San José, Paula: 3 articles (01/2022 - 07/2020)
10. Feldman, Edward C: 3 articles (07/2021 - 05/2008)

Related Diseases

1. Adrenocortical Hyperfunction (Adrenal Gland Hyperfunction)
2. Cushing Syndrome
3. Hyperaldosteronism (Conn Syndrome)
4. Hypertension (High Blood Pressure)
5. Hyperplasia

Related Drugs and Biologics

1. Hydrocortisone (Cortisol)
2. Aldosterone
3. Adrenocorticotropic Hormone (ACTH)
4. Oxidoreductases (Dehydrogenase)
5. 3-Hydroxysteroid Dehydrogenases (3 beta Hydroxysteroid Dehydrogenase)
6. Mitotane (Lysodren)
7. Steroids
8. Enzymes
9. Aminoglutethimide (Cytadren)
10. Metyrapone

Related Therapies and Procedures

1. Therapeutics
2. Subcutaneous Injections
3. Oral Administration
4. Continuous Ambulatory Peritoneal Dialysis (CAPD)
5. Aftercare (After-Treatment)